AAN Recommendations on Symptomatic Treatment for Muscle Cramps
Am Fam Physician. 2010 Sep 1;82(5):540.
Guideline source: American Academy of Neurology
Literature search described? Yes
Evidence rating system used? Yes
Published source: Neurology, February 23, 2010
Available at: http://www.neurology.org/cgi/content/full/74/8/691
Muscle cramps occur when the motor system is stressed by neuromuscular disease, a medical condition, or a physiologic process, such as dehydration or excessive exercise. Cramps are also common during the last trimester of pregnancy. Some patients have frequent, severe muscle cramps that can be disabling.
Quinine sulfate and its derivatives have been the mainstay of therapy for idiopathic muscle cramps. However, they are associated with adverse effects ranging from bitter taste and cinchonism (headache and tinnitus) to hematologic abnormalities such as hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, and bleeding diathesis. In 2006, the U.S. Food and Drug Administration warned against the off-label use of quinine sulfate and its derivatives for this indication, leaving physicians with a difficult choice in selecting a treatment regimen for patients with muscle cramps. The American Academy of Neurology (AAN) recommends that quinine derivatives, although likely effective, not be used routinely in these patients. These agents should be considered only when cramps are disabling and after other pharmacologic therapies have been attempted. Patients must be informed of the potential for serious adverse effects, and should be monitored carefully.
Tonic water contains variable amounts of quinine derivatives. Although there are case reports about its effectiveness in the treatment of muscle cramps, the AAN found insufficient data to make a recommendation for or against its use.
Class 2 studies have shown that the calcium channel blocker diltiazem (Cardizem) and vitamin B complex may be effective for the treatment of muscle cramps. Although no serious adverse effects were reported, minor adverse effects included lightheadedness, nausea, and abdominal discomfort in participants taking vitamin B complex. Magnesium citrate and magnesium sulfate did not notably improve the number of cramps, and were associated with abdominal discomfort and diarrhea.
Several other medications have been used in clinical practice to manage muscle cramps, including the anticonvulsants gabapentin (Neurontin), carbamazepine (Tegretol), and oxcarbazepine (Trileptal). Patients also may try various over-the-counter and nonpharmacologic therapies (e.g., hydration, stretching exercises) before prescription treatment. However, there is little evidence to support the use of any of these therapies.
Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.
Copyright © 2010 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Mar 15, 2018
Access the latest issue of American Family Physician